The Cancer Immunotherapy Consortium is governed by an executive committee who are tasked with further developing the Consortium's mission, choosing its priority projects, and monitoring the program's overall progress.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
Supporters, scientists, patients, and advocates participated in CRI’s annual Wear White Day for a Future Immune to Cancer on June 14, 2019.
CRI hosted a Twitter Chat, moderated by STAT’s Sharon Begley, discussing takeaways from the ASCO19 conference last week.